Agenda Sessions

September 15, 2010

2:00 p.m. - 3:00 p.m.	Registration and Networking
3:00 p.m. - 4:15 p.m.	Financing Strategies for Industrial Biotech Companies Financing Strategies for Industrial Biotech Companies A panel of industry experts will take a closer look at the financial climate for industrial biotech: which companies are receiving funding from the venture capital? How industrial biotechnology companies can take advantage of the government initiatives, such as clean energy legislation and American Recovery and Reinvestment (ARRA)? And how partnership and investment from the big oil affect clean tech company business models. Moderator: Aaron Schuchart, President, SEA Consulting Group Speakers: Christophe Schilling, CEO, Genomatica Bill Haywood, CEO, LS9 James Zhang, Khosla Ventures
4:15 p.m. - 4:45 p.m.	Keynote Presentation Algae Biofuels: Because a Pig Will Not Eat a Lump of Coal Keynote: Greg Mitchell, Board of Directors of the Houston Advanced Research Center, the Algal Biomass Organization, Associate Director, San Diego Center for Algal Biotechnology
4:45 p.m. - 6:00 p.m.	Networking Reception

September 16, 2010

8:00 a.m. - 8:30 a.m.	Registration and networking
8:30 a.m. - 9:30 p.m.	Breakfast Plenary Anatomy of Success What enables companies to succeed? How to plan for it and how to stay on top? What is the past and what is the future for the industrial biotechnology in Northern California and worldwide? One of the oldest industrial biotechnology companies in California is driving the future of innovation in this sector. It has taken more than 20 years of testing, perfecting, and patenting the biomass conversion process to reach this phase of large-scale commercial production. During our breakfast plenary Genencor International will share its story of corporate success, as well as its perspectives on an industry role in making the shift to cost-effective renewable fuels, building the low-carbon economy, and creating economic growth opportunities. Keynote: Michael Arbige, PhD, Senior VP Technology, Genencor International
9:30 a.m. - 10:00 a.m.	Session Break
10:00 a.m. - 12:30 p.m.	Plenary Session The Commercialization Challenge Advances in genetics, biotechnology, process chemistry, and engineering are leading to a new manufacturing concept for converting renewable biomass to valuable fuels and chemical products. Yet cost of oil is unstable and has contracted due to economic crisis. Direct competition with other sources of energy brings into a question commercial success of many companies struggling to contain production costs. Filling the tank without emptying the stomach is another issue to conquer, as well as adapting distribution networks and establishing new regulatory pathways. A panel of industry leaders will focus on commercialization challenge facing California clean technology companies and how they are solving them. Moderator: Brent Erickson, Executive Vice President, Industrial and Environmental Section, BIO Speakers: Ag panel: Jeff Martin, President & CEO, Yulex Rasto Ivanic, Sr. Director, Business Development, Mendel Biotechnology, Inc. BioFuels panel: Martin Sabarsky, JD, MBA, Chief Financial Officer & Chief Operating Officer, HR BioPetroleum Chemicals panel: Jonathan Wolfson, CEO and co-founder, Solazyme Damien Perriman, Vice President of Business Development, Verdezyne
12:30 p.m. - 12:45 p.m.	Session Break
12:45 p.m. - 1:45 p.m.	Lunch
2:00 p.m. - 3:30 p.m.	Closing Plenary Developing Commercial Models in Industrial Biotech This session will explore partnerships, joint ventures, capital issues and more for Industrial Biotech companies. Moderator: M. Wainwright Fishburn, Jr., Partner, Cooley LLP; Vice Chair, BIOCOM Speaker: William Baum, Board of Directors, Genomatica, Inc.